Search results for:
nadofaragene firadenovec-vng
nadofaragene firadenovec-vng
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Adstiladrin |
SUSPENSION, INJECTABLE |
3 x 10<sup>11</sup> viral particles/mL |
|
|
|
|
Last updated: Feb. 13, 2025
Non-formulary. Administration should be deferred to the outpatient setting.
Reviewed: January 2025
Nadofaragene firadenovec-vng (ADSTILADRIN) Spotlight.pdf